Evidence map›Paper›PMID 29211761›Full record

ArticlePloS one2017

Prophetic Granger Causality to infer gene regulatory networks.

Daniel E Carlin, Evan O Paull, Kiley Graim, Christopher K Wong, Adrian Bivol, Peter Ryabinin, Kyle Ellrott, Artem Sokolov, Joshua M Stuart

Abstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Inferring signaling pathways with probabilistic programming.Bioinformatics (Oxford, England) · 2020
    Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Daniel E CarlinUniversity of California San Diego, Department of Medicine, La Jolla, CA, United States of America.
Evan O PaullUniversity of California Santa Cruz, Department of Biomolecular Engineering, Santa Cruz, CA, United States of America.
Kiley GraimUniversity of California Santa Cruz, Department of Biomolecular Engineering, Santa Cruz, CA, United States of America.
Christopher K WongUniversity of California Santa Cruz, Department of Biomolecular Engineering, Santa Cruz, CA, United States of America.
Adrian BivolUniversity of California Santa Cruz, Department of Biomolecular Engineering, Santa Cruz, CA, United States of America.
Peter RyabininUniversity of California Santa Cruz, Department of Biomolecular Engineering, Santa Cruz, CA, United States of America.
Kyle EllrottOregon Health Sciences University, Department of Biomedical Engineering, Portland, OR, United States of America.
Artem SokolovUniversity of California Santa Cruz, Department of Biomolecular Engineering, Santa Cruz, CA, United States of America.
Joshua M StuartUniversity of California Santa Cruz, Department of Biomolecular Engineering, Santa Cruz, CA, United States of America.ORCID http://orcid.org/0000-0002-2171-565X

Funding

Pharmaco Response Signatures and Disease MechanismU54HG006097 · NHGRI · HARVARD MEDICAL SCHOOL · PI MITCHISON, TIMOTHY J, SORGER, PETER KARL · 2010 to 2013
$9.7M
UCSC-Buck Inst. Genome Data Analysis Center for TCGA Research Network (GDAC)U24CA143858 · NCI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI BENZ, CHRISTOPHER, HAUSSLER, DAVID H · 2009 to 2016
$8.9M
BIGDATA: Mid-Scale DCM: DA: ESCE: Discovering Molecular ProcessesR01CA180778 · NCI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI STUART, JOSHUA MICHAEL · 2013 to 2017
$3.5M
New Integrative Pathway Analysis Methods to Predict Biomedical OutcomesR01GM109031 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI STUART, JOSHUA MICHAEL · 2014 to 2018
$2.9M
UCSC-Buck Specialized Genomic Data Analysis Center for the Genomic Data Analysis NetworkU24CA210990 · NCI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI STUART, JOSHUA MICHAEL · 2016 to 2020
$2.2M
NCI NIH HHS R01 CA180778NCI NIH HHS U24 CA143858NCI NIH HHS U24 CA210990NHGRI NIH HHS U54 HG006097NIGMS NIH HHS R01 GM109031
6 · The paper itself

Abstract

We introduce a novel method called Prophetic Granger Causality (PGC) for inferring gene regulatory networks (GRNs) from protein-level time series data. The method uses an L1-penalized regression adaptation of Granger Causality to model protein levels as a function of time, stimuli, and other perturbations. When combined with a data-independent network prior, the framework outperformed all other methods submitted to the HPN-DREAM 8 breast cancer network inference challenge. Our investigations reveal that PGC provides complementary information to other approaches, raising the performance of ensemble learners, while on its own achieves moderate performance. Thus, PGC serves as a valuable new tool in the bioinformatics toolkit for analyzing temporal datasets. We investigate the general and cell-specific interactions predicted by our method and find several novel interactions, demonstrating the utility of the approach in charting new tumor wiring.

Indexed as

CausalityGene Regulatory NetworksComputational BiologyHumansMachine LearningModels, TheoreticalNeoplasmsSystems Biology

Identifiers

PMID29211761
PMCPMC5718405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.